Krystal Biotech Inc
F:4KB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Krystal Biotech Inc
F:4KB
|
US |
|
P
|
PTC Therapeutics Inc
SWB:BH3
|
US |
Wall St Price Targets
4KB Price Targets Summary
Krystal Biotech Inc
According to Wall Street analysts, the average 1-year price target for 4KB is 169.82 EUR with a low forecast of 115.36 EUR and a high forecast of 222.56 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 4KB's stock price target?
Price Target
169.82
EUR
According to Wall Street analysts, the average 1-year price target for 4KB is 169.82 EUR with a low forecast of 115.36 EUR and a high forecast of 222.56 EUR.
What is the Revenue forecast for Krystal Biotech Inc?
Projected CAGR
32%
The compound annual growth rate for Revenue over the next 3 years is 32%.
What is the Gross Profit forecast for Krystal Biotech Inc?
Projected CAGR
38%
The compound annual growth rate for Gross Profit over the next 3 years is 38%.
What is the Operating Income forecast for Krystal Biotech Inc?
Projected CAGR
56%
The compound annual growth rate for Operating Income over the next 3 years is 56%.
What is the Pre-Tax Income forecast for Krystal Biotech Inc?
Projected CAGR
44%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 44%.
What is the Net Income forecast for Krystal Biotech Inc?
Projected CAGR
35%
The compound annual growth rate for Net Income over the next 3 years is 35%.
